Jason M. Vaughn,Justin R. Hughey,Tanesha Roberts,Tatyana Dyakonov,Sunil Agnihotri,Aqeel A. Fatmi
申请号：
US15686352
公开号：
US20170348270A1
申请日:
2017.08.25
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Described herein are pharmaceutical compositions comprising one or more fumarate esters, processes for making the same, and compositions and methods for treating multiple sclerosis subjects with the compositions. In particular, oral pharmaceutical compositions comprising fumarate esters in liquid vehicles are described. One embodiment is an oral delayed release pharmaceutical dosage form comprising a soft capsule encapsulating an immediate releasing liquid comprising one or more fumarate esters.
